SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Johnson Pharmacare - Quaterly Results

09 Nov 2022 Evaluate
A slight decline in the revenue of Rs. 0.00 millions was seen for the September 2022 quarter as against Rs. 17.29 millions during year-ago period.The Net Loss for the quarter ended September 2022 is Rs. -0.44 millions as compared to Net Profit of Rs. 2.69 millions of corresponding quarter ended September 2021Operating profit Margin for the quarter ended September 2022 slipped to -0.44% as compared to 2.69% of corresponding quarter ended September 2021


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 0.00 17.29 0.00 25.27 32.63 -22.56 32.63 7.60 329.34
Other Income 0.38 0.00 0.00 0.38 0.00 0.00 0.00 0.00 0.00
PBIDT -0.44 2.69 -116.36 3.53 4.86 -27.37 1.35 0.02 6650.00
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT -0.44 2.69 -116.36 3.53 4.86 -27.37 1.35 0.02 6650.00
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBT -0.44 2.69 -116.36 3.53 4.86 -27.37 1.35 0.02 6650.00
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.38 0.01 3700.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -0.44 2.69 -116.36 3.53 4.86 -27.37 0.97 0.01 9600.00
Equity 550.00 500.00 10.00 550.00 500.00 10.00 550.00 500.00 10.00
PBIDTM(%) 0.00 15.56 0.00 13.97 14.89 -6.21 4.14 0.26 1471.92

Johnson Pharmacare Share Price

0.62 0.04 (6.90%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Redington 234.90
Adani Enterprises 2218.35
Amrapali Industries 17.53
Rashi Peripheral 455.25
PDS 301.45
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×